The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels

Elevated triglyceride (TG) and reduced high-density lipoprotein-cholesterol (HDL-C) plasma levels are risk factors for atherosclerosis and cardiovascular disease. Therefore, a drug that simultaneously reduces TG and increases HDL-C plasma levels has the potential to prevent and treat these diseases....

Descripción completa

Detalles Bibliográficos
Autor principal: Zhang, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635044/
https://www.ncbi.nlm.nih.gov/pubmed/34869703
http://dx.doi.org/10.3389/fcvm.2021.795370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635044/
https://www.ncbi.nlm.nih.gov/pubmed/34869703
http://dx.doi.org/10.3389/fcvm.2021.795370

Ejemplares similares